Title:  Research Coordinator III

Division:  Duncan Cancer Center
Schedule:  Monday - Friday, 8 am - 5 pm
Work Location:  Texas Medical Center, Houston, TX
Salary Range:  $41,601 - $50,000
FLSA Status:  Exempt
Requisition ID:  7817


The Dan L. Duncan Comprehensive Cancer Center (DLDCCC) has an immediate opening for a Clinical Research Coordinator III. This position serves as one of the primary Breast Oncology clinical research point of contacts in one of only 51 NCI-designated comprehensive cancer centers nationwide (one of three in Texas). The individual must be able to effectively navigate the multitude of studies, regulatory compliance issues of each, and work with a host of external collaborators within the comprehensive cancer center; s/he must be highly skilled and motivated, knowledgeable and can quickly learn the multitude of oncological studies being conducted well enough to quickly and appropriately assess patient eligibility and to engage these patients at a high level.


This position is housed within the Breast Program of the DLDCCC, and will provide support for clinical trials in medical oncology. This individual must be a flexible and detail-oriented professional who can quickly adapt to a variety of situations in a complex oncology environment, and must also be able to balance multiple projects simultaneously.

Job Duties

  • Coordinate clinical research activities with clinical care.  This involves liaising with physicians from multiple specialties, clinic staff, as well as hospital staff, in order to ensure protocol adherence and conduct the study in accordance with Good Clinical Practices.  All of this must be done while simultaneously working to minimize clinic visits, and complete study procedures in a way that they do not interfere with routine clinical care.
  • Comprehensive assessment of adverse events in collaboration with the participant's physician, as well as other care team members, the research coordinator must assess, document, and grade adverse events in accordance with the standardized NCI guidelines.  Furthermore, these adverse events must be reported to the sponsor, as appropriate; the research coordinator must have an understanding of which adverse events require modifications (e.g. dose delays, dose modifications, supportive care, etc.), and adequately communicate this to the treating physician and/or care team.
  • Intimate knowledge of multiple study protocols is required to be able to screen, confirm eligibility, and coordinate the necessary battery of tests/procedures without affecting timeline to starting treatment.
  • Must be able to balance adherence to protocol requirements/timeline while maintaining an appropriate timeline for lifesaving clinical care within an NCI-designated comprehensive cancer center housed within an academic health science center.
  • Must be able to navigate conflicts in scheduling resulting from departmental conflicts, clinics canceled as a result of COVID or weather, which can then produce a domino effect on treatment timelines, response assessments, etc., and ultimately create difficulties in protocol adherence and timely data collection.
  • This position is the primary point of contact for clinical trial participants.  Thus, this individual must be able to discern (in collaboration with departmental physicians) which symptoms are likely related to the investigational product, the disease under study, other medications, or a combination of the above.  This individual must be able to obtain the appropriate information from the patient, decide whether or not to escalate it, and then determine its impact on study conduct.

Minimum Qualifications

  • Bachelor's degree in a related field. Four years of related experience may substitute for degree requirement.
  • Two years of relevant experience.

Preferred Qualifications

  • Bachelor's degree or higher.
  • Three years of experience in clinical research.
  • Oncology experience.





Baylor College of Medicine is an Equal Opportunity/Affirmative Action/Equal Access Employer.